SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524500

INE729D01010

95.2493613

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KILITCH

22.43

624.24

EPS(TTM)

Face Value()

Div & Yield %

7.96

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	188.57	181.59	131.60	117.78	105.16	70.02
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	188.57	181.59	131.60	117.78	105.16	70.02
Other Income	13.85	13.72	6.19	4.60	4.56	4.19
Stock Adjustments	-1.07	1.17	0.12	-0.23	0.05	-1.09
Total Income	201.35	196.48	137.91	122.15	109.77	73.12
EXPENDITURE :
Raw Materials	87.80	93.19	66.33	58.27	60.29	37.97
Power & Fuel Cost	2.61	2.61	2.36	2.15	2.00	1.57
Employee Cost	12.34	10.03	7.91	7.47	6.15	5.22
Other Manufacturing Expenses	6.95	5.52	4.69	5.37	5.91	5.48
Selling & Administrative Expenses	39.37	38.03	26.70	23.08	16.48	11.11
Miscellaneous Expenses	5.27	2.25	3.29	3.88	3.25	2.25
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	154.33	151.64	111.29	100.22	94.08	63.59
Operating Profit	47.02	44.83	26.62	21.94	15.69	9.53
Interest	3.18	2.40	2.02	1.15	0.80	0.88
Gross Profit	43.84	42.43	24.60	20.79	14.89	8.65
Depreciation	2.29	1.74	1.24	1.34	0.96	1.14
Profit Before Tax	41.55	40.69	23.36	19.45	13.93	7.51
Tax	10.86	9.85	6.37	4.20	3.63	1.67
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.70	-0.32	-0.59	-0.47	-0.23	-0.31
Reported Net Profit	32.40	31.16	17.57	15.72	10.53	6.16
Extraordinary Items	4.59	8.10	1.01	0.77	1.00	0.94
Adjusted Net Profit	27.81	23.06	16.56	14.95	9.53	5.22
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	162.69	131.53	113.96	98.24	87.71	81.56
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	195.09	162.69	131.53	113.96	98.24	87.71
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	9.27	19.37	10.93	10.09	6.76	3.97
Earnings Per Share(Adj)-Unit Curr	9.27	9.48	5.35	4.94	3.31	1.94
Book Value-Unit Curr	95.25	157.28	138.61	122.53	112.65	105.16
Book Value(Adj)-Unit Curr	95.25	76.96	67.82	59.95	55.12	51.46

78,009.25 -70.71 ( -0.09%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

68,711.00 402.41 (0.59%)

10,753.31 -19.36 (-0.18%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)